This discovery not only reveals the crucial role of the cAMP/EPAC1/LOX-1 axis in atherosclerosis but also provides new therapeutic ideas for targeted intervention in the EPAC1 signalling pathway to alleviate atherosclerosis. Here, RAPGEF3 is linked to atherosclerosis.